Internal Medicine · Brooklyn, NY
NPI
1891700605
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4819 14th Ave
Brooklyn, NY, 11219
Phone (718) 438-0707
Groups this clinician bills Medicare through
Medicare paid, 2024
$682K
10,194 services
Medicare patients, 2024
731
Average age 75
Drug cost, 2024
$4.3M
28,769 prescriptions
Company payments, 2025
$1,178
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arkadiy Izrailov was code 99490 (chronic, principal, and transitional care management), 2,520 times for 277 patients. In total Arkadiy Izrailov billed 10,194 services in 46 codes, and Medicare paid $682K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 2,520 | 277 | $56.16 | $142K |
| 99213 Office E&M - Established | Office | 2,440 | 561 | $74.16 | $181K |
| 99214 Office E&M - Established | Office | 1,273 | 442 | $110.44 | $141K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 560 | 559 | $12.89 | $7,221 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 545 | 545 | $147.37 | $80K |
| 36415 Venipuncture Blood Collection | Office | 534 | 319 | $8.65 | $4,619 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 527 | 526 | $12.40 | $6,536 |
| 81002 Clinical Chemistry | Office | 399 | 253 | $3.41 | $1,361 |
| 99349 Home E&M - New and Established | Office | 312 | 64 | $108.10 | $34K |
| 99232 Hospital E&M - Subsequent | Facility | 203 | 44 | $67.89 | $14K |
| 99497 Care Management/Coordination | Office | 145 | 143 | $72.11 | $10K |
| G0008 Administration of influenza virus vaccine | Office | 118 | 118 | $37.09 | $4,377 |
| 90662 Vaccine Product | Office | 107 | 107 | $81.82 | $8,755 |
| 93000 Electrocardiogram | Office | 80 | 72 | $13.04 | $1,043 |
| 99233 Hospital E&M - Subsequent | Facility | 80 | 31 | $103.33 | $8,266 |
By year: 2022 $834K for 12,144 services; 2023 $708K for 10,223 services; 2024 $682K for 10,194 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 534 | 319 | $8.65 | $4,619 |
| 81002 Clinical Chemistry | 399 | 253 | $3.41 | $1,361 |
Medicare prescription drug claims, 2024
In 2024, the drug Arkadiy Izrailov prescribed most often to Medicare patients was Amlodipine Besylate, with 955 prescriptions and refills. In total Arkadiy Izrailov wrote 28,769 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 955 | 1,414 | 179 | $2,791 |
| Atorvastatin Calcium Generic | 891 | 1,290 | 150 | $3,869 |
| Rosuvastatin Calcium Generic | 848 | 1,244 | 148 | $5,081 |
| Metformin Hcl Generic | 838 | 1,084 | 134 | $3,787 |
| Metoprolol Succinate Generic | 790 | 1,190 | 144 | $7,962 |
| Losartan Potassium Generic | 707 | 964 | 135 | $2,648 |
| Vascepa Icosapent Ethyl | 647 | 673 | 107 | $223K |
| Diclofenac Sodium Generic | 570 | 594 | 143 | $290K |
| Linzess Linaclotide | 562 | 604 | 102 | $302K |
| Eliquis Apixaban | 514 | 630 | 72 | $387K |
| Omeprazole Generic | 487 | 617 | 95 | $2,194 |
| Valsartan Generic | 482 | 693 | 96 | $5,938 |
| Tamsulosin Hcl Generic | 470 | 837 | 104 | $4,343 |
| Azithromycin Generic | 468 | 468 | 295 | $1,227 |
| Pantoprazole Sodium Generic | 416 | 588 | 94 | $2,416 |
Brand drugs: 7,237 claims; generic drugs: 20,951 claims; opioid claims: 160.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arkadiy Izrailov $1,178 ($1,178 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $374.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 19 | $374 |
| Abbvie Inc. ABBV | 9 | $169 |
| Novo Nordisk Inc NVO | 6 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $87.16 |
| Exact Sciences Corporation EXAS | 3 | $74.91 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $51.17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $34.06 |
| CSL Behring CSL.AX | 1 | $32.34 |
| Pfizer Inc. PFE | 1 | $25.32 |
| Aimmune Therapeutics, Inc. | 1 | $24.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.